Arbutus Biopharma
Stock Forecast, Prediction & Price Target
Arbutus Biopharma Financial Estimates
Arbutus Biopharma Revenue Estimates
Arbutus Biopharma EBITDA Estimates
Arbutus Biopharma Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $10.98M N/A | $39.01M 255.10% | $18.14M -53.50% | Avg: $5.88M Low: $5.19M High: $6.98M avg. -67.58% | Avg: $8.60M Low: $6.55M High: $11.42M avg. 46.34% | Avg: $9.46M Low: $7.21M High: $12.56M avg. 9.96% | Avg: $56.63M Low: $43.17M High: $75.20M avg. 498.47% |
Net Income
% change YoY
| $-77.35M N/A | $-69.45M 10.20% | $-72.84M -4.88% | Avg: $-76.76M Low: $-71.04M High: $-57.78M avg. -5.37% | Avg: $-84.84M Low: $-101.91M High: $-49.37M avg. -10.52% | Avg: $-31.53M Low: $-44.97M High: $-21.78M avg. 62.83% | Avg: $-34.85M Low: $-49.70M High: $-24.08M avg. -10.52% |
EBITDA
% change YoY
| $-71.52M N/A | $-61.03M 14.66% | $-70.98M -16.31% | Avg: $-5.88M Low: $-6.98M High: $-5.19M avg. 91.71% | Avg: $-8.60M Low: $-11.42M High: $-6.55M avg. -46.34% | Avg: $-9.46M Low: $-12.56M High: $-7.21M avg. -9.96% | Avg: $-56.63M Low: $-75.20M High: $-43.17M avg. -498.47% |
EPS
% change YoY
| -$0.73 N/A | -$0.46 36.98% | -$0.44 4.34% | Avg: -$0.39 Low: -$0.43 High: -$0.35 avg. 11.25% | Avg: -$0.43 Low: -$0.61 High: -$0.3 avg. -10.26% | Avg: -$0.19 Low: -$0.27 High: -$0.13 avg. 55.87% | Avg: -$0.21 Low: -$0.3 High: -$0.15 avg. -10.52% |
Operating Expenses
% change YoY
| $82.63M N/A | $102.24M 23.72% | $96.24M -5.86% | Avg: $9.71M Low: $8.57M High: $11.52M avg. -89.91% | Avg: $14.21M Low: $10.83M High: $18.87M avg. 46.34% | Avg: $15.62M Low: $11.91M High: $20.75M avg. 9.96% | Avg: $93.52M Low: $71.28M High: $124.19M avg. 498.47% |
FAQ
What is Arbutus Biopharma stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 9.10% in 2025-2028.
We have gathered data from 4 analysts. Their low estimate is -71.04M, average is -76.76M and high is -57.78M.
What is Arbutus Biopharma stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 121.80% in 2025-2028.
We have gathered data from 4 analysts. Their low revenue estimate is $5.19M, average is $5.88M and high is $6.98M.
What is Arbutus Biopharma stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 11.58% in 2025-2028.
We have gathered data from 4 analysts. Their low earnings per share estimate is -$0.43, average is -$0.39 and high is $-0.34.
What is the best performing analyst?
In the last twelve months analysts have been covering Arbutus Biopharma stock. The most successful analyst is Ed Arce.